Non-emergency angioplasty costs higher in hospitals without back-up surgery

November 5, 2012

Angioplasty costs were higher in hospitals not equipped with emergency back-up heart surgery, compared to those hospitals that are, according to late-breaking clinical trial research presented at the American Heart Association's Scientific Sessions 2012.

During angioplasty, a catheter with a small balloon, often deploying a tube, called a stent, is inserted into a narrowed artery to open it, increase blood flow and reduce symptoms like chest pain. The Cardiovascular Patient Outcomes Research Outcomes of Percutaneous Team (C-PORT-E) clinical trial found that elective angioplasty performed in hospitals without capabilities had similar safety and efficacy as those performed at hospitals with on-site . That finding shifted the focus to whether non-surgery hospitals can perform these procedures at a similar cost.

Increasingly, hospitals without on-site cardiac surgery are opting to offer elective angioplasty in house, rather than transferring patients to hospitals with surgical back-up. To compare cost-effectiveness, this first large, multi-center study of its kind analyzed the expenses associated with non-emergency angioplasty in hospitals with and without cardiac surgery.

Investigators analyzed billing data from 18,273 patients (average age 64, 79 percent white and 63 percent male) treated in 59 hospitals in 10 states.

Nine months after treatment, investigators found that average cumulative were $23,991 in surgery-equipped hospitals, versus $25,460 in non-surgery hospitals. Two factors contributed to this difference—the study protocol required non-surgery hospitals to use intensive care units for post-angioplasty care and patients treated at these hospitals were more likely than those receiving angioplasty at cardiac equipped hospitals to be readmitted nine months after treatment.

"Our findings have relevance for healthcare policymakers and providers," said Eric L. Eisenstein, D.B.A., lead author of the study and assistant professor of medicine, and community and family medicine at Duke University School of Medicine in Durham, N.C. "These results should provide caution for hospitals without cardiac surgery back-up considering the implementation of non-primary, or non-emergency, angioplasty services. There is no guarantee that a community hospital can provide angioplasty services at costs comparable with those of major hospitals with on-site cardiac surgery."

According to the , more than 1 million coronary artery opening procedures are performed each year.

Hospitals considering the addition of non-primary angioplasty services should make sure they will have sufficient patient volume to cover the fixed costs of establishing and operating these facilities, Eisenstein said.

Explore further: Patients fare just as well if their nonemergency angioplasty is performed at hospitals

More information: newsroom.heart.org/pr/aha/document/DISCLOSURES.pdf

Related Stories

Patients fare just as well if their nonemergency angioplasty is performed at hospitals

November 14, 2011
Hospitals that do not have cardiac surgery capability can perform nonemergency angioplasty and stent implantation as safely as hospitals that do offer cardiac surgery. That is the finding of the nation's first large, randomized ...

Community hospitals can safely perform elective angioplasty

March 26, 2012
New evidence shows that with appropriate preparation, angioplasty can be safely and effectively performed at community hospitals without on-site cardiac surgery units, according to research presented today at the American ...

Hospitals without on-site cardiac surgery can perform non-emergency angioplasty safely and effectively

March 26, 2012
(Medical Xpress) -- Patients who have non-emergency angioplasty to open blocked heart vessels have no greater risk of death or complications when they have the procedure at hospitals without cardiac surgery backup. That is ...

Angioplasties performed at centers without on-site surgery services are safe, study finds

December 13, 2011
Contrary to current guidelines, Mayo Clinic researchers have found that angioplasties performed at centers without on-site cardiac surgery capabilities pose no increased risk for patient death or emergency bypass surgery. ...

Most hospitals miss critical window for heart attack transfer patients

November 28, 2011
Most heart attack patients transferred between hospitals for the emergency artery-opening procedure called angioplasty are not transported as quickly as they should be, Yale School of medicine researchers report in the first ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.